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A role for protein phosphorylation in the process of neurite outgrowth has been inferred from many
studies of the effects of protein kinase inhibitors and activators on cultured neurotumor cells and
primary neuronal cells from developing brain or ganglia. Here we re-examine this issue, using a
culture system derived from a fully differentiated neuronal system undergoing axonal regenera-
tion—the explanted goldfish retina following optic nerve crush. Of the relatively non-selective
protein kinase inhibitors employed, H7, staurosporine and K252a were found to block neurite out-
growth, whereas HA 1004 had no effect, a result which appears to rule out a critical role for protein
kinase A. The more selective protein kinase C inhibitors, sphingosine, calphostin C and Ro-31-
8220 were all inhibitory, as was prolonged treatment with phorbol ester and the protein phosphatase
inhibitor okadaic acid. These results are in support of a role for protein kinase C in axonal regrowth.
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INTRODUCTION
Cultured neural cells, both primary and neurotu-
mor-derived, have provided useful model systems for
studies of nerve growth and regeneration. Much progress
has been made in advancing our understanding of the
various aspects of neurite outgrowth. Less well-under-
stood are the factors which regulate this complex pro-
cess. Since modulation of protein phosphorylation/
dephosphorylation events represents a major cellular
regulatory pathway, it is likely that both tyrosine and
serine/threonine protein kinases are major players in the
regulation of neurite outgrowth. Reports of the effects
of protein kinase modulators on neurite outgrowth from
cultured neural cells include inhibitory effects of phorbol
esters (TPA) on mouse neuroblastoma cells (1,2), rat
cerebellar granule cells (3) and chick sensory (4) or rat
sympathetic (5) ganglia and stimulatory effects for hu-
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man neuroblastoma cells (6-9), chick ciliary ganglia
(10), and rat cortical neurons (11). Such results sug-
gested that protein kinase C (PKC) plays a role in neurite
outgrowth/differentiation. However, whether its effect is
positive or negative was unclear, not only because of the
opposite effects cited above, but also due to the fact that
prolonged phorbol ester treatment down-regulates PKC
(12). Studies of the effects of protein kinase inhibitors
have been carried out with PC 12 cells, a cell line which
responds to nerve growth factor (NGF) by the produc-
tion of neurites (13) and early activation of a cascade of
tyrosine and serine/threonine phosphorylations (14), in-
cluding activation of PKC (15). Staurosporine (at low
concentrations; 16), K252a (17-20), sphingosine (21) and
calphostin C (20) all inhibit NGF- dependent neurite out-
growth from PC 12 cells. Although low concentrations
of TPA in the presence of NGF have been reported to
increase neurite outgrowth in PC 12 cells (21), down reg-
ulation of PKC by pretreatment with TPA had no effect
(22). Staurosporine (at higher concentrations) is also re-
ported to increase neurite outgrowth in PC 12 cells
(19,20), however this response appears to be indepen-
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dent of PKC (20). For SH-SY5Y human neuroblastoma
cells, H7, staurosporine, sphingosine and K252a all stim-
ulate neurite outgrowth (9,23), a result in agreement with
the ability of prolonged TPA treatment to cause differ-
entiation of these cells (9,24). In addition, intracellular
delivery of antibodies to specific isoforms of PKC in-
duces morphological differentiation of SH-SY5Y cells
(25). Support for the importance of protein phosphory-
lation state for neurite outgrowth also comes from stud-
ies of the protein phosphatase inhibitor, okadaic acid,
which was found to be inhibitory for both PC 12 cells
(26) and neuroblastoma (27,28).
Primary neuronal cultures also vary in their re-
sponses to protein kinase inhibitors. In rat cortical neu-
ron cultures, H7 treatment, as well as PKC
down-regulation, potentiates the neurite outgrowth re-
sponse to epidermal growth factor (11), whereas, in rat
cerebellar granule cells, down-regulation of PKC, stau-
rosporine and sphingosine treatment each inhibit neurite
outgrowth (3). For chick ciliary ganglia grown on a lam-
inin substratum, short-term TPA treatment enhances
neurite outgrowth, while H7 and sphingosine inhibit
(10), a result which was interpreted to reflect a possible
role for PKC in signal transduction from the laminin
receptor. PKC down-regulation in distal neurites of com-
partmented rat sympathetic neuronal cultures caused a
slowing in the rate of NGF-dependent neurite outgrowth
(5), however, H7 and staurosporine did not inhibit. Al-
though sphingosine (5), calphostin C and chelerythrine
(29), when applied to distal neurite compartments, were
found to be inhibitory, inhibition was not prevented by
PKC down-regulation. Some of the apparently anoma-
lous results with these various culture systems may be
due to the presence of multiple isoforms of PKC (30),
which might differ in their sensitivity to inhibitors and
their ability to be down-regulated by TPA treatment.
The studies thus far carried out involve either dif-
ferentiating neurotumor cells or cultures of developing
neurons. Axonal regeneration may recapitulate some of
the cellular processes invoked in development or could
utilize unique mechanisms not seen in differentiation.
More specific insight into the role of protein kinases in
regenerating axons might be gained by analysis of a
fully differentiated neuronal system such as that pro-
vided by the goldfish retina following optic nerve crush.
The latter treatment induces the retinal ganglion cells to
grow new axons, a process which can be studied in vitro
by explantation of post-crush retina (31,32). Enhanced
phosphorylation of axonal proteins during goldfish optic
nerve regeneration has been observed (33). Here we re-
port that neurite outgrowth from goldfish retinal explants
is inhibited by many of the protein kinase inhibitors de-
scribed above, as well as by the novel, more selective
PKC inhibitor, Ro-31-8220. The data are consistent with
a role for PKC in axonal outgrowth during nerve regen-
eration.
EXPERIMENTAL PROCEDURE
Materials. Protein kinase inhibitors and activators were obtained
as follows: H7 [1-(5-isoquinoline sulfonyl)-2- methylpiperazine] and
HA 1004 [N-(2-guanidinoethly)-5-isoquinolinesulfonamide] from Sei-
kagaku America (Rockville, MD); staurosporine, sphingosine and
phorbo1-12-mysristate-13-acetate (TPA) from Sigma Chemical Co. (St.
Louis, MO); K252a, Calphostin C, and Ro-31-8220 {3-[l-(amidinothio)
propyl-lH-indol-3-yl]-3-(l-methyl-lH-indol-3-yl) maleimide methane
sulfonate from Calbiochem (LA Jolla, CA). The protein phosphatase
inhibitor, okadaic acid, was also purchased from Calbiochem.
Explant Culture. Goldfish (Carassius auratus), 6—7 cm in body
length were obtained from Grassy Forks Fisheries (Martinsville, IN).
Explant cultures were prepared from goldfish retinas following intraor-
bital crush of the optic nerve (under tricaine anesthesia) as previously
described (31,32). Briefly, retinas were removed at 7-21 days follow-
ing optic nerve crush, chopped with a Mcllwain tissue chopper into
500 |xm squares, then placed onto polylysine-coated dishes (30 mm)
and cultured in L-15 medium (Gibco) at 20-22° in a humid chamber.
Each experimental group consisted of 5 dishes containing 9 explants
in a 3 X 3 array. After 7 days in culture, the neurite growth index
(NGI, a measure of neurite length and density; 32) was determined.
Neurite outgrowth was also assayed by an automated program which
utilized digitized video images of the explants (34). Both measures of
neurite outgrowth yielded results which were in good agreement with
each other. Unless otherwise stated, compounds to be tested for their
effects on neurite outgrowth were added to the culture dishes at the
time of explantation and were present throughout the 7 day culture
period.
RESULTS
Neurite Outgrowth Measurements. Initial studies
utilized isoquinoline sulfonyl protein kinase inhibitors:
H7, which shows little selectivity for PKA vs. PKC and
HA 1004, a more potent inhibitor of PKA than of PKC
(35,36). Whereas HA1004 was ineffective at the highest
concentration tested (30 |4M), H7 inhibited neurite out-
growth from goldfish retinal explants with an IC50 of
approximately 5 uM (Fig. 1; Table I). This result sug-
gests that PKA activity is not required for neurite out-
growth in this culture system. H7 was considered
non-toxic to the retinal ganglion cells, since exposure of
the explants to 30 uM H7 for the first 24 hours of culture
followed by washout of the drug, had no effect on sub-
sequent neurite outgrowth. Explants grown on a laminin
substratum showed the same sensitivity to H7 as those
on a polylysine substratum (data not shown). Two ad-
ditional relatively non-selective protein kinase inhibitors,
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Fig. 1. Effect of protein kinase inhibitors on neurite outgrowth from
explants of goldfish retina. Retinal explants were grown for 7 days in
the presence of the indicated concentration of protein kinase inhibitors,
then the nerve growth index (NGI) was determined. Data are expressed
as percent of control NGI, which averaged 2.8 ± 0.2 (mean ± SEM,
n = 20). Each point represents data from 45 explants from one of 2
or 3 experiments which gave similar results.
staurosporine and K252a, were both found to be potent
blockers of neurite outgrowth (Fig 1; Table I). Similar
relative potencies of these two compounds have been
observed for neurite outgrowth inhibition in PC 12 cells
(16,18). Washout of either of these two inhibitors after
24 hour exposure resulted in only partial (30-50%) relief
of the neurite outgrowth inhibition, suggesting either
some irreversible toxicity or inefficiency of the washout
procedure. In order to further explore the possible role
of PKC, the effects of three relatively selective PKC
inhibitors were determined (Fig. 1, Table I). Sphingo-
sine, Ro-31-8220 and calphostin C were all effective in-
hibitors of neurite outgrowth from goldfish retinal
explants. In addition, incubation of retinal explants for
7 days with 1 ^.M TPA, a treatment which would be
expected to cause down-regulation of protein kinase C,
results in 70% inhibition of neurite outgrowth (data not
shown). Okadaic acid, a protein phosphatase inhibitor
(44), resulted in a dose-dependent inhibition of neurite
outgrowth (data not shown), with an IC50 of 5 nM sug-
gesting that type 1 protein phosphatase activity may be
required for neurite outgrowth.
Morphological Studies. The agents examined in this
study may be acting on one or more of three stages of
axonal regrowth: initiation, elongation or maintenance.
In order to explore this issue, goldfish retinal explants
were grown for 4 days in control medium, at which time
protein kinase or phosphatase inhibitors were added and
both the extent of neurite outgrowth and neurite mor-
phology were compared to that of control explants after
an additional 3 days in vitro (Fig. 2). Addition of stau-
rosporine, H7, sphingosine and okadaic acid, at 75-90%
of their maximally effective doses, completely prevented
any further neurite outgrowth. In contrast, K252a treat-
ment resulted in an apparent 20% increase in neurite
outgrowth (p < 0.01), with enhanced fasciculation evi-
dent (Fig. 2e). When viewed under phase contrast (Fig.
3), neurites exposed to H7, sphingosine and okadaic acid
exhibited signs of deterioration, including swelling and
increased numbers of enlarged varicosities. In some of
the sphingosine-treated explants, proximal regions of
neurites were absent. The morphology of staurospor-
ine-treated neurites did not differ markedly from con-
trols.
DISCUSSION
Axonal growth is a complex process, requiring al-
terations in gene expression, synthesis and assembly of
cytoskeleton, synthesis and insertion of new surface
membrane, formation and movement of growth cones,
communication between the cell body and growing
axon, interaction between growing fibers, and recogni-
tion of target tissue. Thus there are many possible sites
for regulation of axonal growth by protein phosphory-
lation. Among the effects of modulation of protein phos-
phorylation state are regulation of the catalytic activity
of proteins and of the efficiency of protein-protein or
protein-nucleic acid interactions. Although the process
of axonal growth is common to both the developing ner-
vous system and neurons capable of axon regeneration
following injury, each might not be expected to respond
identically to perturbation of protein phosphorylation. In
order to assess the role of protein phosphorylation during
axonal growth in a regenerating system, we have ex-
amined the effect of a series of protein kinase and phos-
phatase inhibitors on neurite outgrowth from goldfish
retina explants, which, following a conditioning lesion
of the optic nerve in vivo, become primed to display
vigorous neurite outgrowth in vitro.
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Fig. 2. Effect of protein kinase inhibitors on outgrowth and appearance of existing neurites. Dark field images of retinal explants (500 |im on a
side) grown for 4 days in control medium, then exposed to the following conditions for 3 additional days: A, control; B, 100 nM staurosporine;
C, 30 nM H7; D, 10 uM sphingosine; E, 300 nM K252a, and F, 10 nM okadaic acid.
Of the seven protein kinase inhibitors tested, all but
one, HA 1004, inhibited neurite outgrowth when added
to goldfish retinal explants at the time of explantation.
Comparison of the dose-response curves for H7 and
HA 1004 with their known IC50'S for PKC and PKA in
vitro appeared to rule out a role for PKA. The IC50,s for
the non-selective inhibitors staurosporine and K252a were
somewhat higher than those reported for PKC in vitro,
while that for sphingosine, a PKC-selective inhibitor was
consistent with its reported in vitro effects. For Ro-31-
8220 and calphostin C, IC50,S substantially higher than
those reported for PKC (but still less than for PKA) were
observed. It is not known what intracellular concentra-
tion of these agents is attained when they are added to
an intact cultured cell system. An IC50 similar to that
reported here for Ro-31-8220 was found for inhibition
of rabbit smooth muscle cell proliferation (45). In ad-
dition, it has been reported that the relative affinities of
calphostin C, staurosporine and Ro-31-8220 vary de-
pending on whether PKC is in the cytosolic or the mem-
brane compartment (46), with the latter two inhibiting
membrane-bound PKC more avidly and the former more
effective against the cytosolic form. The data with the
relatively PKC-selective inhibitors, sphingosine, cal-
phostin C and Ro-31-8220 are consistent with a role for
PKC in retinal explant neurite outgrowth. However, both
sphingosine and calphostin C inhibit neurite outgrowth
from PC 12 cells in the absence of any effects of TPA
treatment (20-22). Such a result may call into question
the selectivity of these two agents, but it remains pos-
sible that they may be acting in PC 12 cells on isoforms
of PKC which are resistant to TPA-induced down-reg-
ulation. Ro-31-8220 has not, to our knowledge, been
previously used for studies of neurite outgrowth. Given
the lack of specificity of the effects of many of these
agents, no firm conclusions can be drawn based on the
actions of any one of them, but taken together, the data
support a role for PKC in axonal regrowth from goldfish
retinal ganglion cells, but, with the exception of PKA,
do not exclude a role for other protein kinases. A study
of the effect of kinase inhibitors on growth cone motility
in explant cultures of goldfish retina found no effect of
calphostin C (1 |oM), but observed a reversible growth
cone arrest with H7 (at 200 but not 100 (iM). The use
of additional more selective inhibitors pointed to a role
for myosin light-chain kinase (47). In addition, we have
observed inhibitory effects of the protein phosphatase
inhibitor, okadaic acid, a result also found for PC 12 cells
and SH-SY5Y neuroblastoma (26,27). It may be that
cycles of phosphorylation/dephosphorylation are impor-
tant for the axonal growth process. Whether these inhib-
itors are affecting basal or stimulated protein
phosphorylation is not known. The nature of any such
putative stimulus is open to speculation, but it is not, as
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Fig. 3. Neurite morphology. Phase contrast images (20 X objective) of neurites from retinal explants grown for 4 days in control medium, then
exposed to the following conditions for 3 additional days: A, control; B, 30 jxM H7; C, 10 nM sphingosine, and D, 10 nM okadaic acid.
suggested in the chick ciliary ganglion cell study (10),
due to signal transduction at the laminin receptor, since
the goldfish retinal explants were grown on polylysine-
coated dishes. While growth on laminin or a lami-
nin/polylysine substratum enhances the rate of neurite
outgrowth from retinal explants (48), it does not confer
any additional sensitivity to the PKC inhibitor, H7. Nei-
ther is there convincing evidence that the goldfish retinal
ganglion cells respond to known trophic factors.
In order to examine elongation and maintenance of
neurites apart from the initiation process, five of these
inhibitors were added to explants after 4 days of neurite
outgrowth. Staurosporine, H7, sphingosine, and okadaic
acid blocked further neurite outgrowth, a result which
indicates that the protein phosphorylation state is im-
portant for neurite elongation. However, K252a appeared
to increase neurite outgrowth and fasciculation, suggest-
ing that its inhibitory effect when added at the time of
explantation may be due to an action on neurite initia-
tion. Of possible relevance is a report that the K252a-
induced neurite outgrowth in SH-SY5Y neuroblastoma
cells is accompanied by increased tyrosine phosphory-
lation and activity of the focal adhesion protein tyrosine
kinase (23). Such a postulated action of K252a in goldfish
retinal explants could contribute to the enhanced fascic-
ulation observed with this agent. Of the four agents
which blocked elongation of existing neurites, H7,
sphingosine and okadaic acid treatment resulted in de-
generative changes in the appearance of the neurites,
while the morphology of staurosporine-treated neurites
showed no visible differences from control explants. A
similar effect of sphingosine and lack of effect of Stau-
rosporine was reported for distal neurites of compart-
mented cultures of rat sympathetic neurons (5). H7 is
also reported to alter the actin cytoskeleton of cultured
cells in a PKC-independent manner (49). Although
non-specific toxic actions should be considered, it seems
unlikely that such effects could account for the deterio-
1184 Heacock and Agranoff
ration caused by all three compounds, each of which acts
by distinct mechanisms to perturb the cellular protein
phosphorylation state. It may be that staurosporine
caused subtle or gradual changes that were not apparent
by light microscopy or may be acting by a mechanism
other than protein kinase inhibition. The effects of H7,
sphingosine and okadaic acid imply that axon integrity,
in addition to elongation, may be influenced by modu-
lation of the balance between protein kinase and phos-
phatase activities.
The results of this study complement and extend
those obtained from studies of neurotumor cells and pri-
mary cultures of developing neurons to include axons
from regenerating mature neurons among the population
whose growth is sensitive to perturbation of protein
phosphorylation. They also suggest that this sensitivity
is not a reflection of the differentiation state of the neu-
ron or of a response to trophic factor but instead is an
intrinsic property of the axonal growth process.
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